After more than 50 years it is time for a paradigm shift.

We have created a White Paper describing how continuous aseptic freeze-drying can address the major pain points of pharmaceutical batch freeze-drying such as: time-consuming, inefficient, energy-consuming, and poorly controlled.

With a special case study from the company simAbs on the continuous manufacturing process that consistently produces high-quality Drug Substance of monoclonal antibodies.